Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Monthly Performance Review

18 Jun 2015 07:00

RNS Number : 4893Q
BlueCrest AllBlue Fund Ltd
18 June 2015
 



FOR IMMEDIATE RELEASE

 

18 June 2015

 

BLUECREST ALLBLUE FUND LIMITED

MONTHLY PERFORMANCE REVIEW FOR MAY 2015

"Markets were generally calmer in May"

BlueCrest AllBlue Fund Limited (BCAB) rose by 0.7% in May bringing the return for the year to date to 2.0% (Sterling Class NAV). The rolling 12 month return was 5.2% and volatility remained stable at 2.4%.

Markets were generally calmer in May after the volatility of April, although European government bond markets continued to experience very choppy conditions as Bund yields rose and the protracted Greek negotiations dragged on. Economic data in the US and China were generally softer than expected, although European economies continued to expand modestly. There were no meaningful announcements on monetary policy other than the ECB indicated that it may front-load bond purchases ahead of the summer.

 "The return of fixed income volatility proved fruitful"

Six of the seven strategies produced positive returns in May with BlueTrend the only detractor. BlueCrest Capital International once again performed well, up 1.1% for the month, as trading opportunities improved further in fixed income markets. Gains were seen in all regions with the strongest returns coming from the short bias to European rates. The return of volatility to fixed interest markets has once again provided fruitful scope for profits in the fund. With the uncertainties over Greece and a US rate hike combining with thin summer markets, good opportunities remain. AllBlue's allocation to BlueCrest Capital International has been increased further, by 1.5%, for June to 12.7%. An additional increase is likely in the coming months.

By contrast, the allocation to BlueCrest Emerging Markets has been reduced by 2.0% to 7.0%. The fund generated a good performance in May, up 1.5%, with a strong performance across all regions and most strategies, even as the broad emerging markets universe fell. Latin America saw the strongest performance with particularly strong gains from corporate credit and rates in the region. However, BlueCrest are increasingly cautious on emerging markets with distress observed in a number of markets and better opportunities in developed fixed interest.

BlueCrest Equity Strategies saw the balance of the allocation changes for June with an increase of 0.5% to bring its allocation in AllBlue to 14.0%. BlueCrest Equity Strategies also had a strong month in May, up 2.1%, despite generally flat equity markets. Long-short trading generated the best performance with gains around corporate actions and earnings announcements adding to sector-trading gains, most particularly in financials.

A fee change is being implemented on BlueCrest Mercantile Fund whereby the management fee is being reduced from 2% to 1.5% with effect from 1st June. The performance fee remains at 20%.

 "The board is delighted to welcome Sarita Keen as a director"

The board is delighted to welcome Sarita Keen as a director of BCAB with effect from 3rd June. Sarita has over 25 years experience in the fund services industry in Guernsey and we look forward to introducing her to shareholders in the coming months.

The BCAB share price has been relatively stable to NAV during the month with regular investor buying seen around the 5% discount level. As a result the buyback programme operated infrequently during the month. On 11th June the Company was notified that BlueCrest related entities now hold over 5% of shares in the Company.

 

Disclaimer:

This document is directed only at: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and persons who receive this document who do not fall within (i) or (ii) above should not rely on or act upon this document.

 

This document is issued by BlueCrest AllBlue Fund Limited (the "Company") to and for the information of its existing shareholders and does not in any jurisdiction constitute investment advice or an invitation to invest in the shares or any other securities of the Company or any other entity (body corporate or otherwise).

 

The Company has used reasonable care to ensure that the information included in this document is accurate at the date of its issue, but does not undertake to update or revise the information, including any information relating to AllBlue Limited and its underlying funds (the "Funds") provided by BlueCrest Capital Management (UK) LLP or any member of the BlueCrest group of companies (as applicable) ("BlueCrest"), or guarantee the accuracy of such information. To the extent permitted by law neither the Company, the Funds, BlueCrest nor their directors or officers shall be liable for any loss or damage that anyone may suffer in reliance on such information.

 

The information in this document may be changed by the Company at any time. Past performance cannot be relied on as a guide to future performance. The Company's investment strategy is speculative and entails substantial risks. The value of an investment may go down as well as up and some or all of the total amount invested may be lost. This document may not, in whole or in part, directly or indirectly, be taken, transmitted or distributed into the United States of America, its territories or possessions or made available to any national, resident or citizen of the United States of America or any other jurisdiction where applicable laws prohibit its release, distribution or publication. Any failure to comply with these restrictions may be a violation of the law in relevant jurisdictions.

 

JTC (Guernsey) Limited

Secretary

 

Tel: Guernsey 01481 702400

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQDLFFEQFLBBF
Date   Source Headline
13th Oct 20175:52 pmRNSTransaction in Own Shares
10th Oct 201710:34 amRNSNet Asset Value(s)
6th Oct 20175:19 pmRNSTransaction in Own Shares
5th Oct 20172:55 pmRNSHolding(s) in Company
4th Oct 201710:39 amRNSNet Asset Value(s)
3rd Oct 20176:07 pmRNSHolding(s) in Company
26th Sep 201712:19 pmRNSSuccession Planning Update
26th Sep 201711:06 amRNSDirector's Other Directorship
26th Sep 201710:33 amRNSNet Asset Value(s)
22nd Sep 20175:23 pmRNSTransaction in Own Shares
22nd Sep 20173:44 pmRNSHalf-year Report
19th Sep 201710:38 amRNSNet Asset Value(s)
15th Sep 20175:31 pmRNSTransaction in Own Shares
12th Sep 201710:22 amRNSNet Asset Value(s)
6th Sep 20174:21 pmRNSHolding(s) in Company
6th Sep 20174:18 pmRNSHolding(s) in Company
6th Sep 201710:24 amRNSNet Asset Value(s)
5th Sep 20173:17 pmRNSHolding(s) in Company
31st Aug 20175:22 pmRNSEstimated Creditor Interests
29th Aug 201712:51 pmRNSNet Asset Value(s)
25th Aug 201712:59 pmRNSEstimated Creditors Interest
25th Aug 201712:57 pmRNSNet Asset Value(s)
22nd Aug 201711:11 amRNSNet Asset Value(s)
21st Aug 201710:26 amRNSDirector's Other Directorship
15th Aug 201711:23 amRNSNet Asset Value(s)
11th Aug 20175:07 pmRNSTransaction in Own Shares
8th Aug 201710:14 amRNSNet Asset Value(s)
3rd Aug 20172:25 pmRNSNet Asset Value(s)
31st Jul 20175:07 pmRNSInvestor Communication from AllBlue Limited
28th Jul 20173:37 pmRNSEstimated Creditor Interests
28th Jul 20173:30 pmRNSNet Asset Value(s)
25th Jul 201711:07 amRNSNet Asset Value(s)
19th Jul 20172:59 pmRNSResult of AGM
18th Jul 201712:53 pmRNSNet Asset Value(s)
11th Jul 20171:13 pmRNSNet Asset Value(s)
7th Jul 20179:57 amRNSConfirmation of AllBlue Proceeds Received
6th Jul 201710:14 amRNSNet Asset Value(s)
27th Jun 20179:33 amRNSNet Asset Value(s)
23rd Jun 20175:27 pmRNSTransaction in Own Shares
22nd Jun 201712:11 pmRNSEstimated Creditor Interests
22nd Jun 201712:10 pmRNSNet Asset Value(s)
20th Jun 201712:29 pmRNSNet Asset Value(s)
16th Jun 20175:17 pmRNSTransaction in Own Shares
16th Jun 201712:03 pmRNSHolding(s) in Company
14th Jun 201712:07 pmRNSHolding(s) in Company
13th Jun 201712:20 pmRNSNet Asset Value(s)
8th Jun 20174:26 pmRNSHolding(s) in Company
7th Jun 201711:39 amRNSNet Asset Value(s)
6th Jun 201711:51 amRNSNet Asset Value(s)
6th Jun 201711:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.